Stem Cell Therapeutics gets NOL from Health Canada for phase IIa trial in traumatic brain injury patients
Monday, February 01, 2010 09:00 IST Calgary, Alberta
Stem Cell Therapeutics Corp. (SCT) announced it has received a No Objection Letter (NOL) from Health Canada for the company supported, investigator-led phase IIa, single